[Lipoatrophic diabetes. A therapeutic challenge]

Area of Science:

• Genetics and Metabolic Disorders
• Rare Diseases
• Endocrinology

Background:

• Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive condition.
• Characterized by near-complete absence of adipose tissue, often recognized neonatally.
• Associated with severe metabolic complications including insulin resistance, hypertriglyceridemia, and hepatic steatosis.

Observation:

• This report details a case of CGL diagnosed within the first year of life.
• Clinical and laboratory findings supported the diagnosis.
• Genetic testing confirmed a mutation in the BSCL2 gene.

Findings:

• The patient presented with severe hypertriglyceridemia and diabetes mellitus.
• These metabolic disturbances were refractory to standard therapeutic interventions.
• BSCL2 gene mutation confirmed the diagnosis of CGL.

Implications:

• This case underscores the critical need for early diagnosis of CGL.
• Management of metabolic complications in CGL remains challenging.
• Further research into optimal therapeutic strategies for CGL is warranted to prevent premature morbidity and mortality.